Skip to main content

Implanon FDA Approval History

Last updated by Judith Stewart, BPharm on May 26, 2021.

FDA Approved: Yes (First approved July 18, 2006)
Brand name: Implanon
Generic name: etonogestrel
Dosage form: Implant
Company: Organon
Treatment for: Birth Control

Implanon (etonogestrel) is a single-rod subdermal implant that continually releases a low, steady dose of progestin providing contraceptive effectiveness for a period of up to three years.

Development timeline for Implanon

Jul 18, 2006Approval FDA Approves Implanon (etonogestrel implant) for Contraception
Jun 21, 2005Organon Receives Approvable Letter From FDA for Contraceptive Implant
Nov  3, 2004Akzo Nobel’s Contraceptive Implanon Receives “Approvable” Status from the FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.